Core Laboratories Projects Q4 2026 EPS Between $0.12 and $0.20 Amid Middle East Disruptions
Core Laboratories (CLB) reported improved operational performance in the third quarter of 2026 compared to the previous quarter. CEO Lawrence Bruno noted significant growth across key financial metrics, including higher revenue, operating income, operating margins, and earnings per share. Looking ahead to the fourth quarter of 2026, the company issued an earnings per share (EPS) guidance range of $0.12 to $0.20. Management indicated that these projections are being made against a backdrop of ongoing geopolitical disruptions in the Middle East.
Tickers: $CLB
Topics: earnings per share operating income operational performance revenue growth